BDXBecton Dickinson
Is it growing?
Neither accelerating nor breaking down: revenue growing +17% year on year, but earnings down −39% year on year and operating margin narrowing (−1.1 points).
Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +3% a year.
Trailing-twelve-month earnings per share against a year earlier. Growing slower than revenue, so the growth is costing something.
Trailing-twelve-month operating margin, 10.0% now against 11.1% a year earlier.
All from SEC EDGAR, as of Jun 30, 2026.
Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.
Is BDX growing?
Becton Dickinson has grown revenue 6.9% a year over three years and 3.5% a year over five, with earnings per share compounding at −16%.
Revenue growth, 3-year annual rate · Medical Instruments & Supplies median +9.8% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue
- Revenue growth, 5-year rate
- +3.5%
Revenue growth, 5-year rate · +6.9% over three · growth has picked up over the last three years
- Earnings per share, 3-year rate
- −16%
Earnings per share, 3-year rate · revenue +6.9% · earnings lagged revenue: the growth is costing something
- Years of annual history on file
- 19
Years of annual history on file · FY2007 to FY2025, as filed
Details›
- Revenue FY2021
- $19.1B
- Revenue FY2022
- $18.9B
- Revenue FY2023
- $19.4B
- Revenue FY2024
- $20.2B
- Revenue FY2025
- $21.8B
Annual income statements as filed with the SEC.
Medical Instruments & Supplies
The closest names by size in the same industry